2024-11-20 01:21:17
Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy for People with Squamous Non-Small Cell Lung Cancer
Corporate/ 2023-07-23
Innovent and Lilly Jointly Announce the ...

SAN FRANCISCO and SUZHOU,China,June 3,2021--Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that de...

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial
Corporate/ 2023-07-23
The first hormone replacement therapy fo...

1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release